GILD Gilead to acquire Immunomedics for $21 billion

The acquisition will expand Gilead's portfolio of treatments for various types of cancer.
The deal with Immunomedics provides Gilead (GILD) with Trodelvy, an antibody drug for advanced triple-negative breast cancer. The drug was given accelerated FDA approval in April. (Source CNN Business).

Sell on 1 hour chart
Buy on 7h chart
Sell on 3 day chart, but a trend reversal is very plausible because of that doji candle.

If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.


ok this is great, nice work, keep it up!
+1 Reply
CryptoFundManager ProjectSyndicate
excellent technical setup, and great summary. thumbsup!
+1 Reply
Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out